CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market
Holding CNSP?
Track your performance easily

CNS Pharmaceuticals (CNSP) Financial Statements

904 Followers

CNS Pharmaceuticals Financial Overview

CNS Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-128.905; its P/E ratio is 0.00; CNS Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.53M$ 3.55M$ -5.37M$ -4.52M$ -4.02M
EBITDA$ -2.53M$ 3.55M$ -5.37M$ -4.52M$ -4.02M
Net Income Common Stockholders$ -2.53M$ -3.54M$ -5.38M$ -4.52M$ -4.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.49M$ 815.23K$ 548.72K$ 909.55K$ 4.28M
Total Assets$ 2.47M$ 1.66M$ 1.70M$ 2.33M$ 6.45M
Total Debt$ 123.25K$ 213.10K$ 300.81K$ 41.90K$ 166.40K
Net Debt$ -1.37M$ -602.12K$ -247.91K$ -867.64K$ -4.11M
Total Liabilities$ 6.76M$ 6.09M$ 6.13M$ 4.07M$ 4.00M
Stockholders Equity$ -4.29M$ -4.43M$ -4.43M$ -1.74M$ 2.45M
Cash Flow-
Free Cash Flow$ -1.65M$ -3.19M$ -2.54M$ -3.38M$ -3.40M
Operating Cash Flow$ -1.65M$ -3.19M$ -2.54M$ -3.38M$ -3.40M
Investing Cash Flow--$ -2.16K$ -1.74K-
Financing Cash Flow$ 2.33M$ 3.46M$ 2.18M$ 8.36K$ 2.57M
Currency in USD

CNS Pharmaceuticals Earnings and Revenue History

CNS Pharmaceuticals Debt to Assets

CNS Pharmaceuticals Cash Flow

CNS Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis